Skip NavigationSkip to Content
Return Return to Search Results

A dendrimer-based nanosized contrast agent, dual-labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice

  1. Author:
    Koyama, Y.
    Talanov, V. S.
    Bernardo, M.
    Hama, Y.
    Regino, C. A. S.
    Brechbiel, M. W.
    Choyke, P. L.
    Kobayashi, H.

  2. Author Address

    NCI, Mol Imaging Program, Ctr Canc Res, NIH, Bethesda, MD 20892 USA. NCI, Radiat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA. SAIC Frederick, Res Technol Program, Frederick, MD USA.;Kobayashi, H, NCI, Mol Imaging Program, Ctr Canc Res, NIH, Bldg 10,Rm 1B40,MSC1088,10 Ctr Dr, Bethesda, MD 20892 USA.;Kobayash@mail.nih.gov
    1. Year: 2007
    2. Date: Apr
  2. Journal: Journal of Magnetic Resonance Imaging
    1. 25
    2. 4
    3. Pages: 866-871
  4. Type of Article: Article
  5. ISSN: 1053-1807
  1. Abstract:

    Purpose: To preoperatively and intraoperatively localize the sentinel lymph node (SLN), a single hybrid probe for MR and near infrared (NIR) optical imaging was synthesized and tested. Materials and Methods: A macromolecular MR/NIR optical contrast agent was synthesized based on a similar to 191 gadolinium-labeled contrast agent using generation-6 polyamidoamine dendrimer (G6), which is also labeled with 2 Cy5.5, an NIR fluorophore. After establishing the optimal dose, the agent was injected into mammary glands of 10 normal mice to examine the lymphatic drainage from the breast using a 3T clinical scanner. Immediately after the MRI scan, NIR optical imaging and image-guided surgery were performed to compare the two imaging modalities. Results: To consistently identify the SLNs, we needed to inject 25 mu L of 30 mM [Gd] G6-Cy5.5. All SLNs could be easily identified and resected under NIR optical imaging-guided surgery. Although external NIR optical imaging failed to identify SLNs close to the injection site due to shinethrough, MR lymphography (MRL) consistently identified all SLNs regardless of their location. Conclusion: We have successfully synthesized and tested a dual labeled MR/NIR optical hybrid contrast agent, G6-Cy5.5 for reoperative and intraoperative localization of SLNs.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1002/jmri.20852
  3. View record in Web of Science®
  4. WOS: 000245633300026

Library Notes

  1. No notes added.
NCI at FrederickClose Button

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel